๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT07159906Diffuse Large B-Cell Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma
First Affiliated Hospital of Zhejiang University
Phase 1/2
62
Hangzhou
2025-09-08
Recruiting
A Study of IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell Carcinoma
NCT07087158Renal Cell Carcinoma (RCC)
Imbioray (Hangzhou) Biomedicine Co., Ltd.
Phase 2
30
Shanghai
2025-09-08
Recruiting
Study of RGL-270 Single Drug and Combined With Adebelimab in Patients in Patients at High Risk of Recurrence After Radical Treatment of Malignant Solid Tumors
NCT07348042Tumor, Solid
Xian-Jun Yu
Phase 1
198
Shanghai
2025-09-07
Active, closed
Phase I Clinical Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of LYN101
NCT07178327Osteoporotic Fracture
Shanghai TTM-Bio Technology Co., Ltd
Phase 1
64
Bengbu, Shanghai
2025-09-06
Recruiting
Pharmacokinetic Study of Allisartan Isoproxil Tablets in Healthy Chinese Participants
NCT07174830Healthy Participants
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 4
54
Shenzhen
2025-09-06
Recruiting
Study on Carotenoid-Based Instrumental Index
NCT07198503Skin Carotenoid Status
ChinaNorm
Observational
600
Shanghai
2025-09-06
Recruiting
A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma
NCT07099430Advanced Melanoma
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2
200
Fuzhou, Guangzhou, Nanning, Wuhan, Nanjing, Changchun, Jinan, Shanghai
2025-09-05
Not yet open
AK112 in Non-squamous Non-small Cell Lung Cancer (NSCLC)Patients With Actionable Genomic Alterations (AGA) Who Have Failed to Previous Tyrosine Kinase Inhibitor (TKI) Treatment
NCT07158840Non-Small Cell Lung Cancer
Akeso
Phase 2
60
Guangzhou
2025-09-05
Recruiting
Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia
NCT07144020Acute Myeloid Leukemia
Zhejiang University
Phase EARLY_PHASE1
50
Hangzhou
2025-09-05
Recruiting
The Efficacy and Safety of Pregabalin and Mirogabalin in Patients With Fibromyalgia
NCT07157852Fibromyalgia, Pregabalin, Mirogabalin, Pain
Beijing Tiantan Hospital
Not applicable
674
Beijing
2025-09-05
Recruiting
Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma
NCT07102901Advanced Gastric Cancer, Metastatic Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
351
Harbin, Zhengzhou
2025-09-05
Recruiting
SCRT Followed by CAPOX + Bev ยฑ PD-1 Inhibitor for TNT in LARC
NCT07198165Rectal Cancer, Rectal Adenocarcinoma, Rectal Cancer, Radiotherapy, Rectal Cancer Patients
Ruijin Hospital
Phase 2
104
Shanghai
2025-09-05
Recruiting
A Phase 2 Study of MAX-40279 Combined With Venetoclax and Azacitidine in Unfit Newly Diagnosed Acute Myeloid Leukemia
NCT07743112Acute Myeloid Leukemia
Maxinovel Pty., Ltd.
Phase 2
43
Tianjin
2025-09-05
By invitation
The Study of ENB With Ultra-thin Cryobiopsy in the Diagnosis of Peripheral Pulmonary Nodules
NCT07326072Diagnosis
Beijing Chao Yang Hospital
Not applicable
228
Beijing
2025-09-05
Recruiting
Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease
NCT07148791IgG4 Related Disease, B-cell Mediated Autoimmune Disorders
Chinese PLA General Hospital
Phase 2
9
Beijing
2025-09-05
Recruiting
A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT07288554Chronic Obstructive Pulmonary Disease (COPD)
Bambusa Therapeutics
Phase 1
68
Hefei, Guangzhou, Jiangmen, Qingyuan, Xinxiang, Yichang, Xuzhou, Nanchang
2025-09-05
Recruiting
Acute Effects of Transcutaneous Electrical Nerve Stimulation at Acupoints on Nociceptive Transmission
NCT07267052Pain Management
China Medical University Hospital
Not applicable
35
2025-09-05
Not yet open
Idiopathic Pulmonary Fibrosis Cohort of TCM
NCT07162870Idiopathic Pulmonary Fibrosis (IPF)
Henan University of Traditional Chinese Medicine
Observational
1,000
Zhengzhou
2025-09-05
Recruiting
A Cohort Study Comparing PCSK9 Inhibitor Plus Statin With Statin Monotherapy for Carotid Artery Stenosis
NCT07036991Carotid Artery Stenosis
Changhai Hospital
Observational
406
Shanghai
2025-09-05
Recruiting
CD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma
NCT06850285Lymphoma, B-Cell
Shanxi Bethune Hospital
Not applicable
15
Taiyuan
2025-09-05
Recruiting
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT06973187Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
BeOne Medicines
Phase 3
500
Beijing, Fuzhou, Lanzhou, Guangzhou, Jiangmen, Nanning, Guiyang, Shijiazhuang
2025-09-04
By invitation
To Investigate the Effect of Pulmonary Surfactant With Different Inspired Oxygen Concentrations on the Clinical Outcomes of Very Preterm Infants Under Non-invasive Assisted Ventilation
NCT07235345Neonatal Respiratory Distress Syndrome
Xu Falin
Not applicable
500
Henan
2025-09-04
Recruiting
A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of NEUK203-215 Injection in Adult Chinese Patients With Relapsed/Refractory Autoimmune Diseases
NCT07144462Autoimmune
Neukio Biotherapeutics (Shanghai) Co., Ltd.
Phase EARLY_PHASE1
8
Shanghai
2025-09-04
Recruiting
Clinical Study of Cizutamig in Systemic Lupus Erythematosus
NCT07215663Systemic Lupus Erythematosus (SLE)
Candid Therapeutics
Phase 1
47
Beijing, Guangzhou, Luoyang, Zhengzhou, Changsha, Nanchang, Shenyang, Shanghai
2025-09-04
Recruiting
Zanubrutinib, Obinutuzumab, and Lenalidomide (ZGR) in the Treatment of Newly Diagnosed Splenic B-cell Lymphoma With Prominent Nucleoli (SBLPN): A Prospective, Open-label, Single-arm Clinical Trial
NCT07165769Splenic B-cell Lymphoma/Leukaemia With Prominent Nucleoli๏ผŒSBLPN
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
47
Tianjin
2025-09-04
Recruiting
A Study of GV20-0251 in Advanced or Refractory Solid Tumors
NCT07106827HCC - Hepatocellular Carcinoma, Cholangiocarcinoma, Melanoma, NSCLC (Non-small Cell Lung Cancer)
West China Hospital
Phase 1
10
Chengdu
2025-09-04
Recruiting
A Prospective Phase II Clinical Study of Immunotherapy Combined With Chemotherapy for Stage III Unresectable Non-small Cell Lung Cancer
NCT07082179NSCLC
Jiangsu Cancer Institute & Hospital
Phase 2
33
Nanjing
2025-09-04
Recruiting
A Phase III Study of ESG401 for Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer
NCT06732323Triple-Negative Breast Cancer (TNBC)
Qilu Pharmaceutical Co., Ltd.
Phase 3
504
Beijing
2025-09-04
Recruiting
Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer
NCT07194005Gastric Cancer
Fudan University
Phase 2
30
Shanghai
2025-09-04
Recruiting
BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis
NCT07151690Systemic Light Chain Amyloidosis
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
21
Tianjin
2025-09-04
Recruiting
A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)
NCT07137910Chronic Hepatitis B
Ausper Biopharma Co., Ltd.
Phase 2
200
Beijing, Jilin City, Chongqing, Xiamen, Guangzhou, Shenzhen, Nanning, Zhengzhou
2025-09-04
Recruiting
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation
NCT07139301Ischemic Stroke, Atrial Fibrillation
Capital Medical University
Not applicable
438
Maโ€™anshan, Beijing, Zhangzhou, Heyuan, Qinzhou, Baoding, Harbin, Jiamusi
2025-09-04
Recruiting
DIND in Patients With aSAH : Real World Study
NCT07160088Aneurysmal Subarachnoid Hemorrhage (aSAH)
Xuanwu Hospital, Beijing
Observational
10,000
Beijing
2025-09-03
Recruiting
QL1706+Lenvatinib+AG Regimen as First-line Treatment for Advanced Metastatic Pancreatic Cancer
NCT07110064Advance Pancreatic Cancer
Du Juan
Phase 2
80
Nanjing
2025-09-03
Recruiting
The Study is Being Conducted to Evaluate the Safety and Efficacy of XJN010 Nasal Spray in Patients With Parkinson's Disease Experiencing Off Episodes
NCT07156773Parkinson Disease
Guangzhou Novaken Pharm Co., Ltd.
Phase 2
84
Guangzhou
2025-09-03
Recruiting
Clinical Outcomes After Non-curative Endoscopic Resection in Early Colorectal Cancer: A Multicenter Study
NCT07542171Early Colorectal Cancer, Non-curative Endoscopic Resection
Nanfang Hospital, Southern Medical University
Observational
400
Guangzhou, Shenzhen, Haizhu
2025-09-03
Recruiting
Individual Differences in Cognitive Control Predict Real-time fMRI Neurofeedback Performance
NCT07211269Healthy
University of Electronic Science and Technology of China
Not applicable
40
Chengdu
2025-09-03
Recruiting
A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma
NCT07098403Asthma
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 3
408
Guangzhou
2025-09-03
Recruiting
CD5 CART for the Treatment of Relapsed and Refractory CD5 Hematological Tumors
NCT07234110Relapsed and Refractory CD5 Hematological Tumors
Institute of Hematology & Blood Diseases Hospital, China
Not applicable
18
Tianjin
2025-09-03
Recruiting
A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects
NCT07099118Non - Alcoholic Steatohepatitis
Sunshine Lake Pharma Co., Ltd.
Phase 1
96
Beijing
2025-09-03
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Beijing, Changchun, Changde, Changsha, Changzhou, Chengdu, Chongqing, Daqing
2025-09-02
Active, closed
A Phase II Clinical Study of BW-20507 in Combination With PEG-IFNฮฑ for the Treatment of Hepatitis B
NCT07135349Chronic Hepatitis B
Shanghai Argo Biopharmaceutical Co., Ltd.
Phase 2
209
Hefei, Beijing, Sichuan, Chongqing, Fuzhou, Guangzhou, Shenzhen, Zunyi
2025-09-02
Recruiting
Head dOwn Position Before Endovascular Treatment for Large veSsel Occlusion (HOPES5)
NCT07172789Ischemic Stroke
General Hospital of Shenyang Military Region
Not applicable
210
Shenyang
2025-09-02
Recruiting
cfDNA Methylation for Liver Cancer Recurrence Detection
NCT07466602Primary Liver Cancer
Wuhan Ammunition Life-tech Co., Ltd
Observational
500
Wuhan
2025-09-02
Recruiting
A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
NCT07093814Glioblastoma
Guangzhou Virotech Pharmaceutical Co., Ltd.
Phase 1/2
42
Hefei, Beijing, Chongqing, Guangzhou, Shenzhen, Zhuhai, Nanning, Jinan
2025-09-02
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
NCT07023289Colorectal Cancer
AbbVie
Phase 2
140
2025-09-02
Recruiting
A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors
NCT07169994Advanced Solid Tumors, Breast Cancer, Non Small Cell Lung Cancer
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2
414
Hefei, Fuzhou, Guangzhou, Meizhou, Nanning, Baoding, Harbin, Anyang
2025-09-02
Active, closed
A Multicentre, Retrospective-prospective Real-world Study: to Evaluate the Effectiveness and Safety of Vorasidenib in Patients With Isocitrate Dehydrogenase IDH1/2 Mutant Grade 2 Astrocytoma or Oligodendroglioma (VICTORIA Study)
NCT06969352Gliomas
Servier (Tianjin) Pharmaceutical Co. LTD.
Not applicable
62
Beijing, Qionghai, Chengdu
2025-09-02
Recruiting
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT07164443Metastatic Castration-resistant Prostatic Neoplasms
Janssen Research & Development, LLC
Phase 3
1,203
Beijing, Changchun, Chengdu, Chongqing, Guangzhou, Nanjing, Nanning, Nantong
2025-09-02
Recruiting
Microneedle Intra-Arterial Injection for Retinal Artery Occlusion
NCT07151755Central Retinal Artery Occlusion
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
24
Hangzhou
2025-09-01
Not yet open
Multimodal Identification of Depressive Symptoms in the Elderly
NCT07112118Depression
Wuhan Mental Health Centre
Observational
2,000
Wuhan
2025-09-01
Recruiting
Optimization of taVNS Intervention Strategies for Refractory Constipation
NCT07344402Refractory Constipation
Xijing Hospital of Digestive Diseases
Not applicable
100
Xi'an
2025-09-01
Not yet open
Triple Branched Stent Graft System for Aortic Arch Lesions
NCT07067840Aortic Arch Aneurysm, Aortic Arch Pseudoaneurysm, Aortic Arch Ulcer
Changhai Hospital
Not applicable
96
Shanghai
2025-09-01
Recruiting
Efficacy and Mechanisms of Macitentan for Non-Coronary Obstructive Angina
NCT07392281Non-Coronary Obstructive Angina
China-Japan Friendship Hospital
Phase EARLY_PHASE1
40
Beijing
2025-09-01
Not yet open
Efficacy and Safety of Huanjingjian Decoction in Women With Premature Ovarian Insufficiency
NCT07020429Premature Ovarian Insufficiency
Shanghai Pulmonary Hospital, Shanghai, China
Not applicable
276
Shanghai
2025-09-01
Not yet open
Phase III Trial of Susu Zhike Granules in Children With Cold-cough Syndrome for Acute Cough Treatment
NCT06773117Cough
Tasly Pharmaceutical Group Co., Ltd
Phase 3
360
Hefei, Chongqing, Guangzhou, Zunyi, Xingtai, Kaifeng, Nanyang, Sanmenxia
2025-09-01
Not yet open
RSV in Acute Respiratory Infection Surveillance Among Community-Dwelling Elderly Aged โ‰ฅ50 Years in China
NCT07075029Acute Respiratory Infections (ARIs)
Huashan Hospital
Observational
28,800
Xiamen, Zhuhai, Zunyi, Xinxiang, Yichang, Nanjing, Jiujiang, Shenyang
2025-09-01
Recruiting
Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors
NCT07301814Gastric Cancer, Pancreatic Cancer, Cholangiocarcinoma Cancer, Esophageal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
56
Wuhan
2025-09-01
Recruiting
Rehabilitation Intervention for COPD Combined With Cardiovascular and Cerebrovascular Diseases
NCT07090200Respiratory Diseases, Cardiovascular Diseases, Cerebrovascular Diseases
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
50,000
Wuhan
2025-09-01
Not yet open
The Resistant Starch Intervention for Cognitive Enhancement
NCT07152483Cognitive Impairment, Diet Interventions, Cognitive Decline, Genetic Risk Factors
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
70
Hangzhou
2025-09-01
Not yet open
A Randomized Controlled Study on the Improvement of Medical Experience for Patients With Radiation-induced Oropharyngeal Mucositis Based on the RIS System of the Internet of Things
NCT07126457Head and Neck Cancer, Radiation-Induced Mucositis
Nanfang Hospital, Southern Medical University
Not applicable
110
Guangzhou, Huizhou, Jieyang, Meizhou
2025-09-01
Recruiting
A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects
NCT07319364Fecal Microbiota Transplantation (FMT), Gastrointestinal Neoplasms, Antineoplastic Agents, Drug-related Side Effects and Adverse Reactions
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
90
Zhejiang
2025-09-01
Active, closed
Evaluation of the Safety and Efficacy of a Wideband Electric Pulse Tumor Ablation System for Malignant Pulmonary Nodules
NCT07638228Malignant Pulmonary Nodules, Lung Cancer
Sir Run Run Shaw Hospital
Not applicable
5
Hangzhou
2025-09-01
Active, closed
A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65
NCT07060885Allergic Rhinoconjunctivitis, Allergic Rhinitis
ALK-Abellรณ A/S
Phase 3
327
Beijing, Fuzhou, Guangzhou, Shenzhen, Zhuhai, Nanning, Haikou, Changshacun
2025-09-01
Recruiting
68Ga-XACP3 PET/CT in Prostate Cancer
NCT07242014Prostate Cancer, PET/CT, ACP3
The First Affiliated Hospital of Xiamen University
Not applicable
60
Xiamen
2025-09-01
Recruiting
Prospective Real-World Study of Pathology AI for Glioma Molecular Prediction
NCT07263711Glioma
Nanfang Hospital, Southern Medical University
Observational
2,000
Guangzhou
2025-09-01
Not yet open
Cryoablation Combined With SHR-1701 Plus Famitinib in Patients With Advanced Intrahepatic Cholangiocarcinoma.
NCT07147088Advanced Intrahepatic Cholangiocarcinoma
Fudan University
Phase 2
36
Shanghai
2025-09-01
Recruiting
Contrast-enhanced Ultrasound and Super-resolution Imaging Predict Renal Function Outcome After Nephrectomy
NCT07294859Nephrectomy, Renal Cell Cancer, AKI - Acute Kidney Injury
Jinling Hospital, China
Observational
285
Nanjing
2025-09-01
Recruiting
A Phase I Study of KLA318-2 Nanocrystal Injection
NCT07171034Healthy Participants
Hunan Kelun Pharmaceutical Co., Ltd.
Phase 1
48
Jinan
2025-09-01
Recruiting
Multimodal PET Imaging With 18F-FDG/SV2A/TSPO for Resection Planning in Drug-Resistant Epilepsy
NCT07147309Epilepsy, PET / MR, Synaptic Vesicle Proteins, Microglial Activation
Weibing Miao, PhD
Observational
60
Fuzhou
2025-09-01
By invitation
3D Designed Defocus Lenses on Myopia Control in Children and Adolescents
NCT07284147Myopia Progressing
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
144
Shanghai
2025-09-01
Not yet open
A Phase I/II Study of TRS005 in Combination With Cyclophosphamide, Doxorubicin, and Prednisone๏ผˆT-CHP๏ผ‰ in Previously Untreated Patients With CD20-positive DLBCL
NCT07035379Diffuse Large B-Cell Lymphoma (DLBCL)
Zhejiang Teruisi Pharmaceutical Inc.
Phase 1/2
66
Beijing
2025-09-01
Recruiting
Efficacy of Electroacupuncture for Acute Herpes Zoster-Associated Pain and Biomarker Evaluation
NCT07515885Acute Herpes Zoster
Dexiong Han
Not applicable
228
Hangzhou
2025-09-01
Recruiting
The Efficacy and Safety Study of CAR-T Cells for Functional Cure in HIV-1/AIDS Patients
NCT06880380HIV Infected Individuals, HIV
Institute of Hematology & Blood Diseases Hospital, China
Phase 1
3
Tianjin
2025-09-01
Not yet open
Linperlisib in the Treatment of aPRCA
NCT07031115Acquired Pure Red Cell Aplasia
Peking Union Medical College Hospital
Phase 2
15
Beijing
2025-09-01
By invitation
TACE Treats Nodular Goiter
NCT07258199Nodular Goiter
Peking Union Medical College Hospital
Not applicable
30
Beijing
2025-09-01
Not yet open
Endostatin Adenovirus With Checkpoint Inhibitor in Advanced Head and Neck or Esophageal Cancer
NCT07154108Esophageal Cancer, Head and Neck Cancer (H&Amp;Amp;Amp;N)
Sichuan University
Phase 1
40
Chengdu
2025-09-01
Recruiting
KSV01 Injection for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT07260812Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL)
TCRx Therapeutics Co.Ltd
Phase 1
18
Wuhan
2025-09-01
Recruiting
The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment
NCT07395960Mild Cognitive Impairment, Overweight or Obesity, Elderly
Fudan University
Phase 1/2
54
Shanghai
2025-09-01
Recruiting
ACU-TENS on Pain and Stress Reduction Before and During TUGOR
NCT06910540Oocyte Retrieival and Post Operative Pain Control, Acupuncture
Chinese University of Hong Kong
Not applicable
144
Hong Kong
2025-09-01
Not yet open
Novel Thin Bronchoscope Versus Ultrathin Bronchoscope for the Diagnosis of Peripheral Pulmonary Nodules
NCT07135297Lung Cancer (Diagnosis)
Shanghai Chest Hospital
Not applicable
465
Beijing, Zhengzhou, Nanjing, Ningbo, Shanghai
2025-09-01
Recruiting
Multicentric Database for Solid Pseudopapillary Neoplasm of the Pancreas
NCT07183280Solid Pseudopapillary Neoplasm of the Pancreas
Fudan University
Observational
2,000
Shanghai
2025-09-01
Not yet open
Phrenic Nerve Stimulation for Reducing Ventilation Duration in Acute Cerebral Infarction: A Multicenter Randomized Controlled Trial
NCT07133932Cerebral Infarction, Mechanical Ventilation, Acute Cerebrovascular Accident, Adult
Xuanwu Hospital, Beijing
Not applicable
590
Beijing, Shijiazhuang
2025-09-01
Recruiting
A Randomized Controlled Trial of Combined Bu Shen Yi Qi Decoction and Dehydroepiandrosterone (DHEA) for the Treatment of Ovarian Function Decline
NCT07535983Diminished Ovarian Reserve
Jiangxi University of Traditional Chinese Medicine
Phase 1/2
74
Nanchang
2025-09-01
Recruiting
AI-Assisted Colorimetric Diagnosis of Peri-Implant Mucosal Erythema
NCT07349095Peri-implant Mucositis
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
200
Shanghai
2025-09-01
Recruiting
Individualized Neck Cervical Irradiation Prophylaxis Trial of NPC
NCT07303023Nasopharyngeal Carcinoma (NPC)
Fudan University
Phase 3
462
Shanghai, Hangzhou, Chengdu, Chongqing
2025-09-01
Not yet open
Clinical Validation Study on the Imaging Efficacy of Mobile 4D CBCT Technology for Peripheral Pulmonary Lesions
NCT07149597Peripheral Pulmonary Lesions (PPLs)
Shanghai Chest Hospital
Observational
50
Shanghai
2025-09-01
Recruiting
Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML
NCT07304232Allogeneic Hematopoietic Cell Transplantation (HCT), AML (Acute Myeloid Leukemia)
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
134
Shijiazhuang, Harbin, Tianjin
2025-09-01
Recruiting
High-Resolution CT for Heart
NCT07169201Coronary Artery Disease
Shanghai Zhongshan Hospital
Observational
500
Shanghai
2025-09-01
Recruiting
A Prospective Study of Madecassoside Tablets in Sclerotic Chronic Graft-versus-Host Disease After Allo-HSCT
NCT07606703Chronic Graft-Versus-Host Disease, Graft vs Host Disease
WeiShi
Phase 2
30
Wuhan
2025-09-01
Recruiting
Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer
NCT06561308Endometrioid Endometrial Cancer
Women's Hospital School Of Medicine Zhejiang University
Phase 2
39
Hangzhou
2025-09-01
Recruiting
A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)
NCT06232083Lung Cancer, Esophageal Cancer, Cervical Cancer
Anhui Provincial Hospital
Phase 1
20
Hefei
2025-09-01
Not yet open
CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation
NCT07117305CD7+ Lymphoma, T Cell Lymphoma
Zhengzhou University
Phase 1/2
38
Zhengzhou
2025-09-01
Not yet open
Sacituzumab Tirumotecan Plus Tagitanlimab in Previously Treated Locally Advanced or Metastatic Triple Negative Breast Cancer
NCT07153965Triple Negative Breast Cancer (TNBC), PD-L1 Positive
Tianjin Medical University Cancer Institute and Hospital
Phase 2
47
Tianjin
2025-09-01
Recruiting
Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune Thrombocytopenia
NCT07206823Primacy Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University
Not applicable
30
Suzhou
2025-09-01
Not yet open
The Impact of Various Exercise Intensities on Energy Expenditure Metabolism
NCT07137520Physical Activity
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Observational
100
Shenzhen
2025-09-01
Recruiting
An Exploratory Study on the Efficacy and Safety of Enlonstobart Combined With Concurrent Radiotherapy and Chemotherapy Following Induction Therapy With Enlonstobart Plus Chemotherapy in Patients With Locally Advanced Cervical Cancer.
NCT07776821Uterine Cervical Neoplasms
Tianjin Medical University Cancer Institute and Hospital
Phase 4
31
Tianjin
2025-09-01
Recruiting
Methylprednisolone for Stroke With Large Infarct Core and Post-stroke Lymphocytopenia
NCT07202143Large Infarct Core, Post-stroke Lymphocytopenia
YiLin
Phase 3
200
Fuzhou
2025-09-01
Recruiting
Validation of RCC Predicting Model With Emulated-target Trial
NCT07117227Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC), Tumor Thrombus, Prognosis
Peking University Third Hospital
Observational
4,700
Beijing
2025-09-01
Recruiting
Radical Nephroureterectomy With vs Without Template Lymph Node Dissection in High-Risk Upper Tract Urothelial Carcinoma (T-LND UTUC)
NCT07321210Upper Tract Urothelial Carcinoma, Lymph Node Dissection
Tianjin Medical University Second Hospital
Not applicable
150
Tianjin
2025-09-01
Rows per page Showing 6201–6300 of 19052
Previous 61 62 63 64 65 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=63

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.